Cardiometabolic risk encompasses a cluster of risk factors that predispose individuals to type 2 diabetes and premature CVD, associated with disrupted insulin signalling and largely driven by insulin resistance [54]. This evidence concerns the gene INS and type 2 diabetes mellitus.